Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06589180Not Yet Recruiting

Clinical Outcomes of Placenta Previa - an Individualized Scoring System

Role: collaborator

NCT06589141Not ApplicableNot Yet Recruiting

Comparison Between Metformin and Glyburide in the Management of Gestational Diabetes

Role: collaborator

NCT05533996Not ApplicableUnknown

Body Fat Index for Obstetric Risk Stratification

Role: collaborator

All 3 trials loaded